Questions on chelation therapy
Geller, S.L.
Journal of the Florida Medical Association 73(12): 921-922
1986
ISSN/ISBN: 0015-4148 PMID: 2577826 Document Number: 271463
Document emailed within 1 workday
Related Documents
Soffer, A. 1975: Chelation therapy for arteriosclerosis JAMA 233(11): 1206-1207Godfrey, M.E.; Frackleton, J.P.; Chappell, L.T. 1994: Chelation therapy for intermittent claudication New Zealand Medical Journal 107(990): 495
Giardina, P.J.; Grady, R.W. 2001: Chelation therapy in beta-thalassemia: an optimistic update Seminars in Hematology 38(4): 360-366
O'Brien, S.F.; Kelly, S.E.; Dolphin, P.J.; Russell, J.C. 2000: Chelation therapy in the JCR:LA-cp rat: experimental assessment of a putative antiatherosclerotic treatment Clinical and Investigative Medicine 23(2): 124-131
Chappell, L.T. 1995: EDTA chelation therapy should be more commonly used in the treatment of vascular disease Alternative Therapies in Health and Medicine 1(2): 53-57
Capra, L.; Atti, G.; De Sanctis, V.; Candini, G. 1983: Glucose tolerance and chelation therapy in patients with thalassaemia major Haematologica 68(1): 63-68
Montgomery, M.R. 1986: Advances in medical fraud: chelation therapy replaces Laetrile Journal of the Florida Medical Association 73(9): 681-685
Margolis, S. 1995: Chelation therapy is ineffective for the treatment of peripheral vascular disease Alternative Therapies in Health and Medicine 1(2): 53-56
Rodríguez Galindo, C.; Ortega Aramburu, J.J.; Alonso, J.L.; Albisu, M.; Casaldáliga, J.; Díaz de Heredia, C.; Olivé, T.; Bastida, P. 1994: Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major Medicina Clinica 102(19): 721-724
Flora, S.J.S.; Mittal, M.; Mehta, A. 2008: Heavy metal induced oxidative stress and its possible reversal by chelation therapy Indian Journal of Medical Research 128(4): 501-523
Victery, W.; Miller, C.R.; Goyer, R.A. 1986: Essential trace metal excretion from rats with lead exposure and during chelation therapy Journal of Laboratory and Clinical Medicine 107(2): 129-135
Yver, L.; Maréchaud, R.; Picaud, D.; Touchard, G.; d'Eyzac, A.T.; Matuchansky, C.; Patte, D. 1978: Acute renal failure in the course of occupational lead intoxication. Chelation therapy responsability La Nouvelle Presse Medicale 7(18): 1541-1543
Gordeuk, V.; Thuma, P.; Brittenham, G.; McLaren, C.; Parry, D.; Backenstose, A.; Biemba, G.; Msiska, R.; Holmes, L.; McKinley, E. 1992: Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria New England Journal of Medicine 327(21): 1473-1477
Tolis, G.; Politis, C.; Kontopoulou, I.; Poulatzas, N.; Rigas, G.; Saridakis, C.; Athanasiou, V.; Mortoglou, A.; Malachtari, S.; Ling, N. 1987: Pituitary somatotropic and corticotropic function in patients with beta-thalassemia on iron chelation therapy Birth Defects Original Article Series 23(5a): 449-452
Platis, O.; Anagnostopoulos, G.; Farmaki, K.; Posantzis, M.; Gotsis, E.; Tolis, G. 2004: Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy Pediatric Endocrinology Reviews: Per 2(Suppl 2): 279-281
Kuppusamy, U.R.; Tan, J.A.M.A. 2011: Chelation therapy with desferrioxamine does not normalize ferritin level but attenuates oxidative damage and improves total antioxidant level in Malaysian Chinese beta-thalassaemia major patients West Indian Medical Journal 60(1): 3-8
Toth, P.P. 2012: Addressing key questions with statin therapy Journal of Family Practice 61(6 Suppl): S34-S39
Anokhin, V.N.; Novikova, I.I.; Stulova, M.A. 1980: Debatable questions of rheumatism therapy Klinicheskaia Meditsina 58(4): 50-55
Bodem, G.; Ochs, H.R. 1983: Current questions on digitalis therapy Der Internist 24(3): 135-150
Topál, L. 1999: Questions about the costs of therapy of reflux esophagitis Orvosi Hetilap 140(11): 625-627